KCNK5_HUMAN - dbPTM
KCNK5_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KCNK5_HUMAN
UniProt AC O95279
Protein Name Potassium channel subfamily K member 5
Gene Name KCNK5
Organism Homo sapiens (Human).
Sequence Length 499
Subcellular Localization Membrane
Multi-pass membrane protein .
Protein Description pH-dependent, voltage insensitive, outwardly rectifying potassium channel. Outward rectification is lost at high external K(+) concentrations..
Protein Sequence MVDRGPLLTSAIIFYLAIGAAIFEVLEEPHWKEAKKNYYTQKLHLLKEFPCLGQEGLDKILEVVSDAAGQGVAITGNQTFNNWNWPNAMIFAATVITTIGYGNVAPKTPAGRLFCVFYGLFGVPLCLTWISALGKFFGGRAKRLGQFLTKRGVSLRKAQITCTVIFIVWGVLVHLVIPPFVFMVTEGWNYIEGLYYSFITISTIGFGDFVAGVNPSANYHALYRYFVELWIYLGLAWLSLFVNWKVSMFVEVHKAIKKRRRRRKESFESSPHSRKALQVKGSTASKDVNIFSFLSKKEETYNDLIKQIGKKAMKTSGGGETGPGPGLGPQGGGLPALPPSLVPLVVYSKNRVPTLEEVSQTLRSKGHVSRSPDEEAVARAPEDSSPAPEVFMNQLDRISEECEPWDAQDYHPLIFQDASITFVNTEAGLSDEETSKSSLEDNLAGEESPQQGAEAKAPLNMGEFPSSSESTFTSTESELSVPYEQLMNEYNKANSPKGT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
36UbiquitinationPHWKEAKKNYYTQKL
CCHHHHHHHHHHHHH
58.17-
38PhosphorylationWKEAKKNYYTQKLHL
HHHHHHHHHHHHHHH
19.4426074081
39PhosphorylationKEAKKNYYTQKLHLL
HHHHHHHHHHHHHHH
16.4626074081
40PhosphorylationEAKKNYYTQKLHLLK
HHHHHHHHHHHHHHH
14.6326074081
42UbiquitinationKKNYYTQKLHLLKEF
HHHHHHHHHHHHHHC
30.03-
47UbiquitinationTQKLHLLKEFPCLGQ
HHHHHHHHHCCCCCH
64.76-
77N-linked_GlycosylationQGVAITGNQTFNNWN
CCEEEECCCCCCCCC
29.12UniProtKB CARBOHYD
131PhosphorylationPLCLTWISALGKFFG
HHHHHHHHHHHHHHC
14.70-
150UbiquitinationRLGQFLTKRGVSLRK
HHHHHHHHCCCCHHH
49.67-
266PhosphorylationRRRRRKESFESSPHS
HHHHHHHHHHCCHHH
37.0326657352
269PhosphorylationRRKESFESSPHSRKA
HHHHHHHCCHHHHHC
47.3527251275
270PhosphorylationRKESFESSPHSRKAL
HHHHHHCCHHHHHCH
21.3125159151
275UbiquitinationESSPHSRKALQVKGS
HCCHHHHHCHHCCCC
57.36-
280UbiquitinationSRKALQVKGSTASKD
HHHCHHCCCCCCCCC
33.90-
282PhosphorylationKALQVKGSTASKDVN
HCHHCCCCCCCCCCC
18.32-
283PhosphorylationALQVKGSTASKDVNI
CHHCCCCCCCCCCCH
43.55-
285PhosphorylationQVKGSTASKDVNIFS
HCCCCCCCCCCCHHH
29.49-
286UbiquitinationVKGSTASKDVNIFSF
CCCCCCCCCCCHHHH
64.33-
292PhosphorylationSKDVNIFSFLSKKEE
CCCCCHHHHHCCCHH
22.8323312004
296UbiquitinationNIFSFLSKKEETYND
CHHHHHCCCHHHHHH
67.3721906983
297UbiquitinationIFSFLSKKEETYNDL
HHHHHCCCHHHHHHH
58.36-
300PhosphorylationFLSKKEETYNDLIKQ
HHCCCHHHHHHHHHH
28.8122210691
301PhosphorylationLSKKEETYNDLIKQI
HCCCHHHHHHHHHHH
15.2322210691
306UbiquitinationETYNDLIKQIGKKAM
HHHHHHHHHHHHHHH
43.06-
347PhosphorylationSLVPLVVYSKNRVPT
HHCEEEEEECCCCCC
13.37-
354PhosphorylationYSKNRVPTLEEVSQT
EECCCCCCHHHHHHH
43.90-
371PhosphorylationSKGHVSRSPDEEAVA
HCCCCCCCCCHHHHH
29.2417192257
385PhosphorylationARAPEDSSPAPEVFM
HHCCCCCCCCCHHHH
37.0926657352
410PhosphorylationEPWDAQDYHPLIFQD
CCCCCCCCCCEEEEC
8.02-
437PhosphorylationSDEETSKSSLEDNLA
CCHHHCHHHHHHHCC
39.6625159151
438PhosphorylationDEETSKSSLEDNLAG
CHHHCHHHHHHHCCC
39.2425159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of KCNK5_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of KCNK5_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KCNK5_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
D00640 Propafenone hydrochloride (JP16/USP); Rythmol (TN)
D00740 Procaine hydrochloride (JP16/USP); Novocain (TN)
D08422 Procaine (INN); Solution of novocain (TN)
D08435 Propafenone (INN); Propafenon hexal (TN)
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KCNK5_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-371, AND MASSSPECTROMETRY.

TOP